Early Real-world Safety Data of Darolutamide in Non-metastatic Castrate-resistant Prostate Cancer. Issue 3 (March 2022) - Elumalai, T.; Syndikus, I.; Sundar, S.; Choudhury, A.; Conroy, R.; Birtle, A.